Spurt Pharmaceuticals Private Limited
About Spurt Pharmaceuticals Private Limited
Data last updated:
Spurt Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 July 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2008PTC180774. Its GSTIN is 07AAMCS1809C1ZJ (Delhi).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Sweety Yadav and Sunit Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No.365 Ghari Mohalla Village Badli, New Delhi, Delhi, India – 110042.
As per the financials filed for FY 2024, the company reported a revenue of ₹50.98 Lakh, a decline of 19% compared to the previous year. For the same year it recorded a net profit of ₹39,064 (net margin 0.8%) and EBITDA of ₹3.19 Lakh (EBITDA margin 6.3%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 2% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Spurt Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No.365 Ghari Mohalla Village Badli, New Delhi, Delhi, India – 110042
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Spurt Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Spurt Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Spurt Pharmaceuticals Private Limited, buy the company report.
Financials of Spurt Pharmaceuticals Private Limited
FY 2025 filings availableSpurt Pharmaceuticals Private Limited reported revenue of ₹50.98 Lakh (down 19% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 19% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.19 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹39,064 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.3% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Spurt Pharmaceuticals Private Limited, buy the company report.
Board of directors of Spurt Pharmaceuticals Private Limited
Spurt Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sweety Yadav | Director | 10 Jul 2008 | 18 Years 3 Months | Current |
| Sunit Kumar | Director | 01 Jul 2009 | 17 Years 3 Months | Current |
| Pankaj Kumar | Director | 26 Nov 2015 | 10 Years 10 Months | Current |
Peer comparison
Spurt Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pepcura Pharmaceuticals Private Limited | ₹51.12 Lakh (FY 2025) | 4.0% | Raipur, Chhattisgarh, India | |||
| Mobanit Industries Private Limited | ₹51.1 Lakh (FY 2025) | 1773.0% | Salem, Tamil Nadu, India | |||
| Spurt Pharmaceuticals Private Limitedthis company | ₹50.98 Lakh (FY 2024) | ₹39,064 | 0.8% | -19.0% | New Delhi, Delhi, India | |
| Markecho Pharmaceuticals Private Limited | ₹50.83 Lakh (FY 2024) | 17.0% | Andheri, Mumbai, Maharashtra, India | |||
| Endear Pharma Private Limited | ₹50.81 Lakh (FY 2021) | 347.0% | Bijnor, Uttar Pradesh, India |
To see the full peer comparison of Spurt Pharmaceuticals Private Limited, buy the company report.
Auditor
Spurt Pharmaceuticals Private Limited is audited by SACHDEVA BAGGA & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SACHDEVA BAGGA & ASSOCIATES | FY 2020 | 017557N |
Shareholding
The shareholding of Spurt Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Spurt Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Spurt Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Spurt Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Spurt Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAMCS1809C1ZJ | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Spurt Pharmaceuticals Private Limited, buy the company report.
Recent activity
Spurt Pharmaceuticals Private Limited has 7 board changes on record since 2008: 3 appointments and 4 cessations. The latest: Pankaj Kumar ceased to be Additional Director on 30 Sep 2016.
Frequently asked questions
Spurt Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 July 2008 (18+ years old) and is registered under CIN U24232DL2008PTC180774.
Spurt Pharmaceuticals has 3 current directors:
- Sweety Yadav - Director
- Sunit Kumar - Director
- Pankaj Kumar - Director
The latest financial statements of Spurt Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Spurt Pharmaceuticals is 07AAMCS1809C1ZJ, registered in Delhi.
The CIN (Corporate Identification Number) of Spurt Pharmaceuticals is U24232DL2008PTC180774. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spurt Pharmaceuticals was incorporated on 10 July 2008, making it 18+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Spurt Pharmaceuticals by revenue are Pepcura Pharmaceuticals Private Limited, Mobanit Industries Private Limited, Markecho Pharmaceuticals Private Limited, Endear Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Pankaj Kumar ceased to be Additional Director on 30 Sep 2016. Dheeraj Sharma ceased to be Director on 26 Nov 2015. Pankaj Kumar was appointed as Director on 26 Nov 2015. Spurt Pharmaceuticals has 7 board changes on record in total.
The registered office of Spurt Pharmaceuticals is at H.No.365 Ghari Mohalla Village Badli, New Delhi, Delhi, India – 110042.
Spurt Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Spurt Pharmaceuticals is compliant as of 02 August 2026. The company is actively filing with the Registrar of Companies.